Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Rhythm Pharmaceuticals
RYTM
$6.66B
| $987K | ﹤0.01% |
40,290
-915
| -2% | -$22.4K |
|
2727
Microvast
MVST
$913M
| $984K | ﹤0.01% |
543,283
+2,395
| +0.4% | +$4.34K |
|
2728
Miller Industries
MLR
$454M
| $981K | ﹤0.01% |
46,070
+1,225
| +3% | +$26.1K |
|
|
KBAL
2729
DELISTED
Kimball International
KBAL
| $980K | ﹤0.01% |
155,935
-948
| -0.6% | -$5.96K |
|
2730
Universal Electronics
UEIC
$62.8M
| $978K | ﹤0.01% |
49,746
-870
| -2% | -$17.1K |
|
2731
First Bancorp
FNLC
$304M
| $976K | ﹤0.01% |
35,406
-1,716
| -5% | -$47.3K |
|
2732
Tarsus Pharmaceuticals
TARS
$2.29B
| $976K | ﹤0.01% |
57,018
-2,052
| -3% | -$35.1K |
|
|
VLTA
2733
DELISTED
Volta Inc.
VLTA
| $975K | ﹤0.01% |
806,128
+467,289
| +138% | +$565K |
|
2734
Allient
ALNT
$774M
| $969K | ﹤0.01% |
33,875
-869
| -3% | -$24.9K |
|
2735
GrowGeneration
GRWG
$89.1M
| $969K | ﹤0.01% |
277,002
-7,548
| -3% | -$26.4K |
|
2736
Community Health Systems
CYH
$409M
| $965K | ﹤0.01% |
449,005
-1,648,413
| -79% | -$3.54M |
|
2737
5E Advanced Materials
FEAM
$91.6M
| $965K | ﹤0.01% |
4,131
-20
| -0.5% | -$4.67K |
|
2738
Athira Pharma
ATHA
$15M
| $961K | ﹤0.01% |
113,794
+2,589
| +2% | +$21.9K |
|
2739
Comtech Telecommunications
CMTL
$65.3M
| $959K | ﹤0.01% |
95,854
+2,432
| +3% | +$24.3K |
|
|
PCSB
2740
DELISTED
PCSB Financial Corporation
PCSB
| $942K | ﹤0.01% |
52,526
-7,821
| -13% | -$140K |
|
|
DNMR
2741
DELISTED
Danimer Scientific, Inc.
DNMR
| $941K | ﹤0.01% |
7,975
+217
| +3% | +$25.6K |
|
2742
BCB Bancorp
BCBP
$149M
| $940K | ﹤0.01% |
55,839
-146
| -0.3% | -$2.46K |
|
2743
KB Financial Group
KB
$30.8B
| $938K | ﹤0.01% |
31,116
+7,172
| +30% | +$216K |
|
|
TPC
2744
Tutor Perini Corporation
TPC
$3.29B
| $937K | ﹤0.01% |
169,795
-6,513
| -4% | -$35.9K |
|
2745
ThredUp
TDUP
$1.33B
| $936K | ﹤0.01% |
508,725
+105,242
| +26% | +$194K |
|
2746
Tredegar Corp
TG
$271M
| $934K | ﹤0.01% |
98,877
-7,145
| -7% | -$67.5K |
|
2747
FVCBankcorp
FVCB
$240M
| $933K | ﹤0.01% |
60,799
+639
| +1% | +$9.81K |
|
|
NPKI
2748
NPK International Inc.
NPKI
$899M
| $932K | ﹤0.01% |
370,168
-5,847
| -2% | -$14.7K |
|
2749
Omega Flex
OFLX
$341M
| $931K | ﹤0.01% |
10,051
-39
| -0.4% | -$3.61K |
|
2750
Hudson Technologies
HDSN
$441M
| $926K | ﹤0.01% |
125,981
+797
| +0.6% | +$5.86K |
|